Navigation Links
Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse (POP) Now Available from the Specialists at Women’s Excellence in Bladder Control in Clarkston, MI

Clarkston, MI (PRWEB) January 17, 2013

Pelvic Organ Prolapse (POP) results when the supportive muscles and connective tissues of a woman’s pelvic organs (uterus, bladder, and bowel) become weakened or damaged. Causes of this weakness and damage include straining, heavy lifting, obesity, constipation, multiple vaginal deliveries, genetics, smoking, and the aging process. There are different types of POP: cystocele (bladder), rectocele ( rectum), enterocele (small bowel), uterine, and vaginal vault (after hysterectomy).

In the case of a cystocele, the bladder descends into the vaginal canal resulting in urinary control problems such as stress urinary incontinence (SUI), overactive bladder (OAB), and urge incontinence. Likewise, a rectocele occurs when the rectum protrudes in the posterior vaginal canal, causing constipation and difficulty with defecating. With a uterine prolapse, the patient will often feel a “bulge” in the vagina as the uterus descends down the vaginal canal. A vaginal vault prolapse occurs after a hysterectomy due to the uterus being removed and tension no longer being applied to the vagina any longer.

Fortunately, women no longer have to suffer with the consequences of POP. There are many minimally-invasive and robotic surgical options to treat these conditions and restore a woman’s anatomy to its proper location. Minimally-invasive procedures usually require no hospital stay and recovery time is much shorter than a standard surgery. Robotic procedures are by their very nature minimally-invasive. Incisions are smaller, hospitals stays are not necessary, and recovery time is quick. According to Dr. Jonathan Zaidan MD, board certified specialist and owner of Women’s Excellence in Bladder Control, “These minimally-invasive and robotic procedures can correct all types of POP and offers the patient a quick, immediate fix to the problem and that is exactly what the patient wants – a quick, easy, stress-free solution to their problem”.

Pelvic Organ Prolapse can be diagnosed from a simple gynecologic exam and some basic in-office, on-site testing such as urodynamics and ultrasound. The patient is first scheduled for an initial consultation with a nurse practitioner, appropriate testing is ordered then the patient has a follow-up visit with a physician to discuss the test results and treatment plan. According to Debbie Henry, NP-C, nurse practitioner at Women’s Excellence in Endometriosis, “We have streamlined the care here at Women’s Excellence in Bladder Control. Our goal is to deliver the excellent care in a timely manner. Patients want their problem to be addressed quickly and accurately and that’s exactly what we do”.

Founded by Dr. Jonathan Zaidan, Women’s Excellence is the most comprehensive obstetric and gynecologic office in Michigan specializing in minimally invasive surgical procedures, treatment of female urinary incontinence and other female urological conditions, as well as minimally invasive vaginal and pelvic organ prolapse conditions. The knowledgeable, well trained, compassionate physicians and healthcare providers of Women’s Excellence are now accepting new patients. Call for an appointment today or visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Fox Valley Orthopedics Surgeon Dr. Craig Popp Says New Minimally Invasive Herniated Disc Surgery Less Painful
2. New technique for minimally invasive robotic kidney cancer surgery
3. Minimally invasive lymph node dissection in breast cancer has advantages over conventional surgery
4. Minimally invasive surgery works well for abdominal aortic aneurysms, Mayo finds
5. Obese appendectomy patients have fewer complications with minimally invasive operations
6. Long-term survival after less-invasive repair of abdominal aneurysm same as with open procedure
7. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
8. Researchers develop non-invasive technique for predicting patients response to chemotherapy
9. Vijay Tiwari awarded prestigious grant to study how cancer cells transform to become invasive
10. NHS should replace traditional autopsies with non-invasive alternative
11. Illy Trieste Science Prize: Yuk Ming Dennis Lo awarded for non-invasive prenatal diagnosis
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since the start ... scientific research and discoveries, leading us to better understand the disease’s behavior. Globally, ... affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides insight on ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... amputations in the United States. Podiatrists are well aware that psychology-based patient non-compliance ... behaviors) are often catastrophic contributors to diseases of the diabetic foot. The ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates mobile imaging results ... subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they are demonstrating new ... America (RSNA) 2015 annual meeting through December 3 in Chicago, Illinois, at Booth ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , a leader ... leadership since 2008. Gary Bruce, President of PartnerTech North America, currently serves as ... significant amount of time in Sweden since joining PartnerTech based in Malmo, Sweden. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: